William Guyer insider trades
Open-market stock purchases and sales by William Guyer, Chief Development Officer at Corcept Therapeutics Inc, from SEC Form 4 filings since Sep 1, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 1, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | $18.6K |
| Sep 1, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| Aug 10, 2026 | CORT Corcept Therapeutics Inc | Sold | $1.3M |
| Aug 10, 2026 | CORT Corcept Therapeutics Inc | Sold | $544K |
| Aug 10, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | $353K |
| Aug 10, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| Aug 4, 2026 | CORT Corcept Therapeutics Inc | Sold | $419K |
| Aug 4, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | $80.1K |
| Aug 4, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| Jul 7, 2026 | CORT Corcept Therapeutics Inc | Sold | $1.8M |
| Jul 7, 2026 | CORT Corcept Therapeutics Inc | Sold | $89K |
| Jul 7, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | $433K |
| Jul 7, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| Jun 2, 2026 | CORT Corcept Therapeutics Inc | Sold | $1.4M |
| Jun 2, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| Jun 1, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| May 5, 2026 | CORT Corcept Therapeutics Inc | Sold | $1M |
| May 5, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| Apr 7, 2026 | CORT Corcept Therapeutics Inc | Sold | $819K |
| Apr 7, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| Mar 20, 2026 | CORT Corcept Therapeutics Inc | Sold | $424K |
| Mar 20, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| Mar 4, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| Mar 4, 2026 | CORT Corcept Therapeutics Inc | Sold | $296K |
| Mar 2, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
Companies traded
- CORT Corcept Therapeutics Inc: 42 sales, last Sep 1, 2026